VRPXVirpax Pharmaceuticals, Inc.

Nasdaq virpaxpharma.com


$ 3.16 $ 0.18 (6.22 %)    

Tuesday, 23-Apr-2024 15:58:43 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 3.1
$ 3.09
$ 0.00 x 0
$ 3.38 x 100
$ 3.09 - $ 3.16
$ 2.40 - $ 11.77
5,246
na
3.63M
$ 0.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 12-07-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 on-april-2-virpax-pharmaceuticals-inc-got-letter-from-nasdaq-stating-that-company-was-not-in-compliance-with-nasdaq-listing-rule

- SEC Filing

Core News & Articles

As part of the settlement, the parties have agreed to a cash payment from Virpax to the Plaintiffs of $3.5 million by March 1, ...

 virpax-pharmaceuticals-announced-the-initial-results-from-the-pilot-study-for-probudur-performed-by-the-us-army-institute-of-surgical-research-under-an-existing-cooperative-research-and-development-agreement

This study was designed to determine if Probudur reduces pain behaviors in a rat model of incisional pain. Two concentrations o...

 why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

 why-getaround-shares-are-trading-higher-by-around-86-here-are-20-stocks-moving-premarket

Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increas...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION